Outcome of Clinical Stage III Melanoma Patients with FDG-PET and Whole-Body CT Added to the Diagnostic Workup

被引：0
|
作者：
M. G. Niebling
E. Bastiaannet
O. S. Hoekstra
J. J. Bonenkamp
R. Koelemij
H. J. Hoekstra
机构：
[1] University Medical Centre Groningen,Department of Surgical Oncology
[2] University of Groningen,Department of Surgery
[3] Leiden University Medical Centre,Department of Gerontology & Geriatrics
[4] Leiden University Medical Centre,Department of Nuclear Medicine & PET Research
[5] VU University Medical Centre,Department of Surgery
[6] Radboud University Nijmegen Medical Centre,Department of Surgery
[7] St. Antonius Hospital Nieuwegein,undefined
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Melanoma; Lymph Node Metastasis; Melanoma Patient; Breslow Thickness; Palpable Lymph Node;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3098 / 3105
页数：7
相关论文
共 50 条
  • [1] Outcome of Clinical Stage III Melanoma Patients with FDG-PET and Whole-Body CT Added to the Diagnostic Workup
    Niebling, M. G.
    Bastiaannet, E.
    Hoekstra, O. S.
    Bonenkamp, J. J.
    Koelemij, R.
    Hoekstra, H. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (09) : 3098 - 3105
  • [2] Survival and Recurrence in Clinical Stage III Melanoma Patients with Whole Body FDG-PET and CT Added to the Diagnostic Work-up
    Niebling, M.
    Bastiaannet, E.
    Hoekstra, O.
    Bonenkamp, H.
    Koelemij, R.
    Hoekstra, H. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S100 - S100
  • [3] FDG-PET/CT response and outcome of neoadjuvant immunotherapy for clinical stage III melanoma.
    Silva, Milton Jose De Barros E.
    Liz, Caio Dabbous
    Teixeira, Marcos Rezende
    Rinck, Jose Augusto
    Tavares, Monique Celeste
    Garcia, Daniel
    Lima, Joao Paulo S. N.
    Lobo, Matheus
    Pinto, Clovis
    Cavicchioli, Marcelo
    Lima, Eduardo
    Molina, Andre
    Gollob, Kenneth
    Figueiredo, Amanda
    Duprat, Joao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Diagnostic performance of whole-body FDG-PET and CT imaging in malignant lymphomas.
    Martínez-Lázaro, R
    Cortés-Blanco, A
    Zhuang, HM
    Alavi, AA
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 277P - 277P
  • [5] Whole-body tumor staging: MRI or FDG-PET/CT?
    Antoch, G
    Vogt, FM
    Bockisch, A
    Ruehm, SG
    [J]. RADIOLOGE, 2004, 44 (09): : 882 - 888
  • [6] Clinical application of whole-body [18F]-FDG-PET in malignant melanoma
    Steinert, HC
    [J]. POSITRON EMISSION TOMOGRAPHY: CRITICAL ASSESSMENT OF RECENT TRENDS, 1998, 51 : 213 - 222
  • [7] FDG-PET or PET/CT in the diagnostic workup of patients with CUP in the head and neck
    Linke, R.
    Zenk, J.
    Keller, F.
    Waldfahrer, F.
    Iro, H.
    Kuwert, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S229 - S229
  • [8] Radiation exposure of patients undergoing whole-body FDG-PET/CT examinations
    Brix, G.
    Nosske, D.
    Lechel, U.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2014, 53 (05): : 217 - 220
  • [9] Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma
    Hausmann, Daniel
    Jochum, Susanne
    Utikal, Jochen
    Hoffmann, Richard Christian
    Zechmann, Christian
    Neff, Kurt Wolfgang
    Goerdt, Sergij
    Schoenberg, Stefan Oswald
    Dinter, Dietmar Joerg
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (03): : 212 - 221
  • [10] Value of whole-body FDG-PET in the routine staging of malignant melanoma
    Bender, H
    Frohmann, JP
    Grapow, M
    Hamad, K
    Schomburg, AS
    Reinhold, U
    Willkomm, P
    Gruenwald, F
    Ruhlmann, J
    Biersack, HJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 331 - 331
12345